$PFE Headlines
Stock investors trash market darlings, face Apple, Fed 8:00 a.m. Jan. 26, 2014 - Wallace Witkowski
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Audit: Medicare overpays for penis pumps 6:48 p.m. Jan. 14, 2014 - blogs.marketwatch.com
A contrarian take on the market’s correction 12:48 p.m. Jan. 9, 2014 - Mark Hulbert
Statin usefulness questioned, but patent expirations may ease pain 1:02 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Cholesterol drugs: Do you need them, or not? 5:00 a.m. Jan. 8, 2014 - Elizabeth O'Brien
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Dairy company Emmi acquires 50% stake in Mexideli 5:36 a.m. Jan. 3, 2014 - MarketWatch.com
10 stocks for the U.S. economy’s revival in 2014 10:14 a.m. Dec. 27, 2013 - Diana Furchtgott-Roth
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - blogs.marketwatch.com
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - blogs.marketwatch.com
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer lung-cancer drug fails in two Phase III studies 7:26 a.m. Today - Seeking Alpha
MRK: Merck Stock a Strong Performer In the Pharma Space 3:00 a.m. Jan. 26, 2014 - InvestorPlace.com
Hey, Big Spender! 4:55 a.m. Jan. 25, 2014 - Barrons.com
5 New Drugs That Could Be Blockbusters in 2014 3:42 a.m. Jan. 25, 2014 - Barrons.com
Week Ahead: Fed Taper Decision, Earnings 5:11 p.m. Jan. 24, 2014 - FOXBusiness
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:01 p.m. Jan. 24, 2014 - TheStreet.com
Bristol-Myers Revenue Improves 1:27 p.m. Jan. 24, 2014 - WSJ.com
Turbocharged Dividends 8:05 a.m. Jan. 24, 2014 - Barrons.com
Earnings Fail to Impress the Market - Earnings Preview 3:41 a.m. Jan. 24, 2014 - Zacks.com
Drug Makers Tiptoe Back Into Antibiotics 5:10 p.m. Jan. 23, 2014 - WSJ.com
Will Bristol-Myers (BMY) Beat Q4 Earnings? - Analyst Blog 4:45 p.m. Jan. 23, 2014 - Zacks.com
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study; Meets Primary Endpoint 7:00 a.m. Jan. 23, 2014 - benzinga.com
More Great Dividend Stocks From Great Britain 6:29 a.m. Jan. 23, 2014 - Seeking Alpha
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease 2:00 p.m. Jan. 22, 2014 - Seeking Alpha
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 6:31 a.m. Jan. 22, 2014 - benzinga.com
Facebook Cements Position Among Most Traded Stocks 6:08 a.m. Jan. 22, 2014 - 247WallSt.com
Pfizer Finds Success With Chantix Clinical Study 7:44 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Is Johnson & Johnson Enticing After Recent Headlines? 5:02 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants? 11:14 a.m. Jan. 21, 2014 - 247WallSt.com
Pfizer treatment to stop smoking meets endpoints 10:58 a.m. Jan. 21, 2014 - Seeking Alpha
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Today - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Stock investors trash market darlings, face Apple, Fed 8:00 a.m. Jan. 26, 2014 - Wallace Witkowski
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Audit: Medicare overpays for penis pumps 6:48 p.m. Jan. 14, 2014 - blogs.marketwatch.com
A contrarian take on the market’s correction 12:48 p.m. Jan. 9, 2014 - Mark Hulbert
Statin usefulness questioned, but patent expirations may ease pain 1:02 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Cholesterol drugs: Do you need them, or not? 5:00 a.m. Jan. 8, 2014 - Elizabeth O'Brien
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Dairy company Emmi acquires 50% stake in Mexideli 5:36 a.m. Jan. 3, 2014 - MarketWatch.com
10 stocks for the U.S. economy’s revival in 2014 10:14 a.m. Dec. 27, 2013 - Diana Furchtgott-Roth
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - blogs.marketwatch.com
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - blogs.marketwatch.com
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer lung-cancer drug fails in two Phase III studies 7:26 a.m. Today - Seeking Alpha
MRK: Merck Stock a Strong Performer In the Pharma Space 3:00 a.m. Jan. 26, 2014 - InvestorPlace.com
Hey, Big Spender! 4:55 a.m. Jan. 25, 2014 - Barrons.com
5 New Drugs That Could Be Blockbusters in 2014 3:42 a.m. Jan. 25, 2014 - Barrons.com
Week Ahead: Fed Taper Decision, Earnings 5:11 p.m. Jan. 24, 2014 - FOXBusiness
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:01 p.m. Jan. 24, 2014 - TheStreet.com
Bristol-Myers Revenue Improves 1:27 p.m. Jan. 24, 2014 - WSJ.com
Turbocharged Dividends 8:05 a.m. Jan. 24, 2014 - Barrons.com
Earnings Fail to Impress the Market - Earnings Preview 3:41 a.m. Jan. 24, 2014 - Zacks.com
Drug Makers Tiptoe Back Into Antibiotics 5:10 p.m. Jan. 23, 2014 - WSJ.com
Will Bristol-Myers (BMY) Beat Q4 Earnings? - Analyst Blog 4:45 p.m. Jan. 23, 2014 - Zacks.com
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study; Meets Primary Endpoint 7:00 a.m. Jan. 23, 2014 - benzinga.com
More Great Dividend Stocks From Great Britain 6:29 a.m. Jan. 23, 2014 - Seeking Alpha
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease 2:00 p.m. Jan. 22, 2014 - Seeking Alpha
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 6:31 a.m. Jan. 22, 2014 - benzinga.com
Facebook Cements Position Among Most Traded Stocks 6:08 a.m. Jan. 22, 2014 - 247WallSt.com
Pfizer Finds Success With Chantix Clinical Study 7:44 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Is Johnson & Johnson Enticing After Recent Headlines? 5:02 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants? 11:14 a.m. Jan. 21, 2014 - 247WallSt.com
Pfizer treatment to stop smoking meets endpoints 10:58 a.m. Jan. 21, 2014 - Seeking Alpha
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Today - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
